Novel contributions of the smoothelin-like 1 protein in vascular smooth muscle contraction and its potential involvement in myogenic tone

Microcirculation

Volumn 21, Issue 3, 2014, Pages 249-258

  Turner, Sara R ^a   Macdonald, Justin A ^a  

^a LIBIN CARDIOVASCULAR INSTITUTE OF ALBERTA   (Canada)

Author keywords

Calcium sensitization; Cerebral; CHASM; Myosin phosphatase; MYPT1; Smoothelin; SMTN; SMTNL1

Indexed keywords

CALCIUM ION; MYOSIN LIGHT CHAIN PHOSPHATASE; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; SMOOTHELIN; SMOOTHELIN LIKE 1 PROTEIN; UNCLASSIFIED DRUG; MUSCLE PROTEIN; PHOSPHOPROTEIN; PPP1R14A PROTEIN, MOUSE; SMTNL1 PROTEIN, HUMAN; SMTNL1 PROTEIN, MOUSE;

ACTIN FILAMENT; ACTIN POLYMERIZATION; ALTERNATIVE RNA SPLICING; ARTICLE; CALCIUM TRANSPORT; HUMAN; MEMBRANE DEPOLARIZATION; MICROCIRCULATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM; SMOOTH MUSCLE CONTRACTILITY; SMOOTH MUSCLE CONTRACTION; SMOOTH MUSCLE TONE; VASCULAR SMOOTH MUSCLE; ANIMAL; ARTERIOLE; BRAIN; CALCIUM SIGNALING; DEFICIENCY; FEMALE; GENETICS; METABOLISM; MOUSE; MUSCLE CONTRACTION; MUSCLE DEVELOPMENT; PHYSIOLOGY; POLYMERIZATION; PREGNANCY; VASCULARIZATION; VASOCONSTRICTION;

ACTIN CYTOSKELETON; ANIMALS; ARTERIOLES; BRAIN; CALCIUM SIGNALING; FEMALE; HUMANS; MICE; MUSCLE CONTRACTION; MUSCLE DEVELOPMENT; MUSCLE PROTEINS; MUSCLE, SMOOTH, VASCULAR; MYOSIN-LIGHT-CHAIN PHOSPHATASE; PHOSPHOPROTEINS; POLYMERIZATION; PREGNANCY; VASOCONSTRICTION;

EID: 84898041636     PISSN: 10739688     EISSN: 15498719     Source Type: Journal    
DOI: 10.1111/micc.12108     Document Type: Article

References (66)

1. Ahn DS, Choi SK, Kim YH, Cho YE, Shin HM, Morgan KG, Lee YH. Enhanced stretch-induced myogenic tone in the basilar artery of spontaneously hypertensive rats. J Vasc Res 44: 182-191, 2007.
2. Amano M, Ito M, Kimura K, Fukata Y, Chihara K, Nakano T, Matsuura Y, Kaibuchi K. Phosphorylation and activation of myosin by Rho-associated kinase (Rho-kinase). J Biol Chem 271: 20246-20249, 1996.
3. Bai N, Moien-Afshari F, Washio H, Min A, Laher I. Pharmacology of the mouse-isolated cerebral artery. Vasc Pharmacol 41: 97-106, 2004.
4. Bar H, Wende P, Watson L, Denger S, van Eys G, Kreuzer J, Jahn L. Smoothelin is an indicator of reversible phenotype modulation of smooth muscle cells in balloon-injured rat carotid arteries. Basic Res Cardiol 97: 9-16, 2002.
5. Bayliss WM. On the local reactions of the arterial wall to changes of internal pressure. J Physiol 28: 220-231, 1902.
6. Bodoor K, Lontay B, Safi R, Weitzel DH, Loiselle D, Wei Z, Lengyel S, McDonnell DP, Haystead TA. Smoothelin-like 1 protein is a bifunctional regulator of the progesterone receptor during pregnancy. J Biol Chem 286: 31839-31851, 2011.
7. Borman MA, Freed TA, Haystead TA, MacDonald JA. The role of the calponin homology domain of smoothelin-like 1 (SMTNL1) in myosin phosphatase inhibition and smooth muscle contraction. Mol Cell Biochem 327: 93-100, 2009.
8. Borman MA, MacDonald JA, Haystead TA. Modulation of smooth muscle contractility by CHASM, a novel member of the smoothelin family of proteins. FEBS Lett 573: 207-213, 2004.
9. Cipolla MJ, Gokina NI, Osol G. Pressure-induced actin polymerization in vascular smooth muscle as a mechanism underlying myogenic behaviour. FASEB J 16: 72-76, 2002.
10. Cole WC, Welsh DG. Role of myosin light chain kinase and myosin light chain phosphatase in the resistance arterial myogenic response to intravascular pressure. Arch Biochem Biophys 510: 160-173, 2011.
11. D'Angelo G, Davis MJ, Meininger GA. Calcium and mechanotransduction of the myogenic response. Am J Physiol Heart Circ Physiol 273: H175-H182, 1997.
12. Davis MJ, Hill MA. Signaling mechanisms underlying the vascular myogenic response. Physiol Rev 79: 387-423, 1999.
13. Davis MJ, Wu X, Nurkiewicz TR, Kawasaki J, Davis GE, Hill MA, Meininger GA. Integrins and mechanotransduction of the vascular myogenic response. Am J Physiol Heart Circ Physiol 280: H1427-H1433, 2001.
14. Deng JT, Van Lierop JE, Sutherland C, Walsh MP. Ca2+-independent smooth muscle contraction. a novel function for integrin-linked kinase. J Biol Chem 276: 16365-16373, 2001.
15. Eto M. Regulation of cellular protein phosphatase-1 (PP1) by phosphorylation of the CPI-17 family, C-kinase-activated PP1 inhibitors. J Biol Chem 284: 35273-35277, 2009.
16. Eto M, Senba S, Morita F, Yazawa M. Molecular cloning of a novel phosphorylation-dependent inhibitory protein of protein phosphatase-1 (CPI17) in smooth muscle: its specific localization in smooth muscle. FEBS Lett 410: 356-360, 1997.
17. Gimona M, Djinovic-Carugo K, Kranewitter WJ, Winder SJ. Functional plasticity of CH domains. FEBS Lett 513: 98-106, 2002.
18. Gokina NI, Park KM, McElroy-Yaggy K, Osol G. Effects of Rho kinase inhibition on cerebral artery myogenic tone and reactivity. J Appl Physiol 98: 1940-1948, 2005.
19. Grassie ME, Moffat LD, Walsh MP, MacDonald JA. The myosin phosphatase targeting protein (MYPT) family: a regulated mechanism for achieving substrate specificity of the catalytic subunit of protein phosphatase type 1delta. Arch Biochem Biophys 510: 147-159, 2011.
20. Grassie ME, Sutherland C, Ulke-Lemee A, Chappellaz M, Kiss E, Walsh MP, MacDonald JA. Cross-talk between Rho-associated kinase and cyclic nucleotide-dependent kinase signaling pathways in the regulation of smooth muscle myosin light chain phosphatase. J Biol Chem 287: 36356-36369, 2012.
21. Gunst SJ, Zhang W. Actin cytoskeletal dynamics in smooth muscle: a new paradigm for the regulation of smooth muscle contraction. Am J Physiol Cell Physiol 295: C576-C587, 2008.
22. Hao H, Gabbiani G, Camenzind E, Bacchetta M, Virmani R, Bochaton-Piallat ML. Phenotypic modulation of intima and media smooth muscle cells in fatal cases of coronary artery lesion. Arterioscler Thromb Vasc Biol 26: 326-332, 2006.
23. Ihara E, MacDonald JA. The regulation of smooth muscle contractility by zipper-interacting protein kinase. Can J Physiol Pharmacol 85: 79-87, 2007.
24. Ishida H, Borman MA, Ostrander J, Vogel HJ, MacDonald JA. Solution structure of the calponin homology (CH) domain from the smoothelin-like 1 protein: a unique apo-calmodulin-binding mode and the possible role of the C-terminal type-2 CH-domain in smooth muscle relaxation. J Biol Chem 283: 20569-20578, 2008.
25. Jarajapu YP, Knot HJ. Relative contribution of Rho kinase and protein kinase C to myogenic tone in rat cerebral arteries in hypertension. Am J Physiol Heart Circ Physiol 289: H1917-H1922, 2005.
26. Jiang J, Nakayama T, Shimodaira M, Sato N, Aoi N, Sato M, Izumi Y, Kasamaki Y, Ohta M, Soma M, Matsumoto K, Kawamura H, Ozawa Y, Hinohara S, Doba N, Ma Y. Association of the smoothelin (SMTN) gene with cerebral infarction in men: a haplotype-based case-control study. Vasc Med 17: 317-325, 2012.
27. Jiang J, Nakayama T, Shimodaira M, Sato N, Aoi N, Sato M, Izumi Y, Kasamaki Y, Ohta M, Soma M, Matsumoto K, Kawamura H, Ozawa Y, Ma Y. Haplotype of smoothelin gene associated with essential hypertension. Hereditas 149: 178-185, 2012.
28. Jiang J, Nakayama T, Shimodaira M, Sato N, Aoi N, Sato M, Izumi Y, Kasamaki Y, Ohta M, Soma M, Matsumoto K, Kawamura H, Ozawa Y, Ma Y. A haplotype of the SMTN gene associated with myocardial infarction in Japanese women. Genet Test Mol Biomarkers 16: 1019-1026, 2012.
29. Johnson RP, El-Yazbi AF, Takeya K, Walsh EJ, Walsh MP, Cole WC. Ca2+ sensitization via phosphorylation of myosin phosphatase targeting subunit at threonine-855 by Rho kinase contributes to the arterial myogenic response. J Physiol 587: 2537-2553, 2009.
30. Khatri JJ, Joyce KM, Brozovich FV, Fisher SA. Role of myosin phosphatase isoforms in cGMP-mediated smooth muscle relaxation. J Biol Chem 276: 37250-37257, 2001.
31. Khromov A, Choudhury N, Stevenson AS, Somlyo AV, Eto M. Phosphorylation-dependent autoinhibition of myosin light chain phosphatase accounts for Ca2+ sensitization force of smooth muscle contraction. J Biol Chem 284: 21569-21579, 2009.
32. Kim HR, Gallant C, Leavis PC, Gunst SJ, Morgan KG. Cytoskeletal remodeling in differentiated vascular smooth muscle is actin isoform dependent and stimulus dependent. Am J Physiol Cell Physiol 295: C768-C778, 2008.
33. Kim JI, Young GD, Jin L, Somlyo AV, Eto M. Expression of CPI-17 in smooth muscle during embryonic development and in neointimal lesion formation. Histochem Cell Biol 132: 191-198, 2009.
34. Kitazawa T, Kobayashi S, Horiuti K, Somlyo AV, Somlyo AP. Receptor-coupled, permeabilized smooth muscle. Role of the phosphatidylinositol cascade, G-proteins, and modulation of the contractile response to Ca2+. J Biol Chem 264: 5339-5342, 1989.
35. Knot HJ, Nelson MT. Regulation of arterial diameter and wall [Ca2+] in cerebral arteries of rat by membrane potential and intravascular pressure. J Physiol 508: 199-209, 1998.
36. Lagaud G, Gaudreault N, Moore ED, Van Breemen C, Laher I. Pressure-dependent myogenic constriction of cerebral arteries occurs independently of voltage-dependent activation. Am J Physiol Heart Circ Physiol 283: H2187-H2195, 2002.
37. Lin LJ, Tang FK, Hua N, Lu H, Di CX, Tang XZ, Li Y. Time-course changes of myogenic tone of mesenteric small artery in spontaneously hypertensive rat. Acta Physiol Sinica 64: 62-68, 2012.
38. Lontay B, Bodoor K, Weitzel DH, Loiselle D, Fortner C, Lengyel S, Zheng D, Devente J, Hickner R, Haystead TA. Smoothelin-like 1 protein regulates myosin phosphatase-targeting subunit 1 expression during sexual development and pregnancy. J Biol Chem 285: 29357-29366, 2010.
39. Lu Y, Zhang H, Gokina N, Mandala M, Sato O, Ikebe M, Osol G, Fisher SA. Uterine artery myosin phosphatase isoform switching and increased sensitivity to SNP in a rat L-NAME model of hypertension of pregnancy. Am J Physiol Cell Physiol 294: C564-C571, 2008.
40. MacDonald JA, Ishida H, Butler EI, Ulke-Lemee A, Chappellaz M, Tulk SE, Chik JK, Vogel HJ. Intrinsically disordered N-terminus of calponin homology-associated smooth muscle protein (CHASM) interacts with the calponin homology domain to enable tropomyosin binding. Biochemistry 51: 2694-2705, 2012.
41. Mederos y Schnitzler M, Storch U, Meibers S, Nurwakagari P, Breit A, Essin K, Gollasch M, Gudermann T. Gq-coupled receptors as mechanosensors mediating myogenic vasoconstriction. EMBO J 27: 3092-3103, 2008.
42. Moreno-Dominguez A, Colinas O, El-Yazbi A, Walsh EJ, Hill MA, Walsh MP, Cole WC. Ca2+ sensitization due to myosin light chain phosphatase inhibition and cytoskeletal reorganization in the myogenic response of skeletal muscle resistance arteries. J Physiol 591: 1235-1250, 2013.
43. Murata-Hori M, Fukuta Y, Ueda K, Iwasaki T, Hosoya H. HeLa ZIP kinase induces diphosphorylation of myosin II regulatory light chain and reorganization of actin filaments in nonmuscle cells. Oncogene 20: 8175-8183, 2001.
44. Niessen P, Clement S, Fontao L, Chaponnier C, Teunissen B, Rensen S, van Eys G, Gabbiani G. Biochemical evidence for interaction between smoothelin and filamentous actin. Exp Cell Res 292: 170-178, 2004.
45. Niessen P, Rensen S, van Deursen J, De Man J, De Laet A, Vanderwinden JM, Wedel T, Baker D, Doevendans P, Hofker M, Gijbels M, van Eys G. Smoothelin-a is essential for functional intestinal smooth muscle contractility in mice. Gastroenterology 129: 1592-1601, 2005.
46. Niiro N, Ikebe M. Zipper-interacting protein kinase induces Ca(2 + )-free smooth muscle contraction via myosin light chain phosphorylation. J Biol Chem 276: 29567-29574, 2001.
47. Ohanian V, Gatfield K, Ohanian J. Role of the actin cytoskeleton in G-protein-coupled receptor activation of PYK2 and paxillin in vascular smooth muscle. Hypertension 46: 93-99, 2005.
48. Osol G, Brekke JF, McElroy-Yaggy K, Gokina NI. Myogenic tone, reactivity, and forced dilatation: a three-phase model of in vitro arterial myogenic behavior. Am J Physiol Heart Circ Physiol 283: H2260-H2267, 2002.
49. Payne MC, Zhang HY, Shirasawa Y, Koga Y, Ikebe M, Benoit JN, Fisher SA. Dynamic changes in expression of myosin phosphatase in a model of portal hypertension. Am J Physiol Heart Circ Physiol 286: H1801-H1810, 2004.
50. Ren Y, D'Ambrosio MA, Liu R, Pagano PJ, Garvin JL, Carretero OA. Enhanced myogenic response in the afferent arteriole of spontaneously hypertensive rats. Am J Physiol Heart Circ Physiol 298: H1769-H1775, 2010.
51. Rensen SS, Thijssen VL, De Vries CJ, Doevendans PA, Detera-Wadleigh SD, Van Eys GJ. Expression of the smoothelin gene is mediated by alternative promoters. Cardiovasc Res 55: 850-863, 2002.
52. Schubert R, Lehmann G, Serebryakov VN, Mewes H, Hopp HH. cAMP-dependent protein kinase is in an active state in rat small arteries possessing a myogenic tone. Am J Physiol Heart Circ Physiol 277: H1145-H1155, 1999.
53. Schubert R, Lidington D, Bolz SS. The emerging role of Ca2+ sensitivity regulation in promoting myogenic vasoconstriction. Cardiovasc Res 77: 8-18, 2008.
54. Schubert R, Mulvany MJ. The myogenic response: established facts and attractive hypotheses. Clin Sci (Lond) 96: 313-326, 1999.
55. Su W, Xie Z, Liu S, Calderon LE, Guo Z, Gong MC. Smooth muscle-selective CPI-17 expression increases vascular smooth muscle contraction and blood pressure. Am J Physiol Heart Circ Physiol 305: H104-H113, 2013.
56. Takizawa N, Schmidt DJ, Mabuchi K, Villa-Moruzzi E, Tuft RA, Ikebe M. M20, the small subunit of PP1M, binds to microtubules. Am J Physiology Cell Physiol 284: C250-C262, 2003.
57. Ulke-Lemee A, Turner SR, Mughal SH, Borman MA, Winkfein RJ, MacDonald JA. Mapping and functional characterization of the murine smoothelin-like 1 promoter. BMC Mol Biol 12: 10, 2011.
58. van der Loop FT, Gabbiani G, Kohnen G, Ramaekers FC, van Eys GJ. Differentiation of smooth muscle cells in human blood vessels as defined by smoothelin, a novel marker for the contractile phenotype. Arterioscler Thromb Vasc Biol 17: 665-671, 1997.
59. van Eys GJ, Voller MC, Timmer ED, Wehrens XH, Small JV, Schalken JA, Ramaekers FC, van der Loop FT. Smoothelin expression characteristics: development of a smooth muscle cell in vitro system and identification of a vascular variant. Cell Struct Funct 22: 65-72, 1997.
60. Velasco G, Armstrong C, Morrice N, Frame S, Cohen P. Phosphorylation of the regulatory subunit of smooth muscle protein phosphatase 1M at Thr850 induces its dissociation from myosin. FEBS Lett 527: 101-104, 2002.
61. Walsh MP, Cole WC. The role of actin filament dynamics in the myogenic response of cerebral resistance arteries. J Cereb Blood Flow Metab 33: 1-12, 2013.
62. Wehrens XH, Mies B, Gimona M, Ramaekers FC, Van Eys GJ, Small JV. Localization of smoothelin in avian smooth muscle and identification of a vascular-specific isoform. FEBS Lett 405: 315-320, 1997.
63. Wooldridge AA, Fortner CN, Lontay B, Akimoto T, Neppl RL, Facemire C, Datto MB, Kwon A, McCook E, Li P, Wang S, Thresher RJ, Miller SE, Perriard JC, Gavin TP, Hickner RC, Coffman TM, Somlyo AV, Yan Z, Haystead TA. Deletion of the protein kinase A/protein kinase G target SMTNL1 promotes an exercise-adapted phenotype in vascular smooth muscle. J Biol Chem 283: 11850-11859, 2008.
64. Xie Z, Su W, Guo Z, Pang H, Post SR, Gong MC. Up-regulation of CPI-17 phosphorylation in diabetic vasculature and high glucose cultured vascular smooth muscle cells. Cardiovasc Res 69: 491-501, 2006.
65. Yuen S, Ogut O, Brozovich FV. MYPT1 protein isoforms are differentially phosphorylated by protein kinase G. J Biol Chem 286: 37274-37279, 2011.
66. Zou H, Ratz PH, Hill MA. Role of myosin phosphorylation and [Ca2+]i in myogenic reactivity and arteriolar tone. Am J Physiol Heart Circ Physiol 269: H1590-H1596, 1995.